| Name | Title | Contact Details |
|---|
Research Diets is a New Brunswick, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ritter Pharmaceuticals, Inc. is a specialty pharmaceutical company developing therapeutics based upon colonic adaptation to treat gastrointestinal diseases with an initial focus on lactose intolerance. Colonic adaptation improves colon function by selectively increasing the growth of beneficial bacteria in the colonic ecosystem (digestive tract). Ritter Pharmaceuticals, Inc. is rapidly establishing itself as the world`s leader in lactose intolerance research based upon its scientific team and their cutting edge research in this field. RP-G28, Ritter`s lead product, has been studied in a Phase 2 trial and is a first-in-class compound. RP-G28 has the potential to become the first FDA-approved drug for the treatment of lactose intolerance, a debilitating disease which affects over 1 billion people worldwide.
Share Our Selves is a Costa Mesa, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Biomedical Implant Technology is a St Catharines, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Pearl City Nursing Home is a Pearl City, HI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.